Federal Trade Commission v. Mylan Laboratories

Full title: FEDERAL TRADE COMMISSION Plaintiff, v. MYLAN LABORATORIES, INC., CAMBREX…

Court: United States District Court, D. Columbia

Date published: Mar 14, 2000

98-CV-3114 (TFH), 98-CV-3115 (TFH) (D.D.C. Mar. 14, 2000)

Opinion

98-CV-3114 (TFH), 98-CV-3115 (TFH)

March 14, 2000

ORDER TO COMPEL PUREPAC PHARMACEUTICAL COMPANY TO PRODUCE THE IDENTITY OF ITS SUPPLIERS OF LORAZEPAM API AND ITS LORAZEPAM CUSTOMERS

THOMAS F. HOGAN, United States District Judge.

Upon consideration of the parties motion to compel Purepac Pharmaceutical Company to Produce Documents, IT IS Hereby ORDERED:

That Purepac Pharmaceuticals Company produce data and documents without redacting

(1) the identity of any active pharmaceutical ingredient (API) manufacturer or any agent of any API manufacturer from whom Purepac either did or tried to purchase lorazepam API and

(2) identity of its lorazepam customers.